Cargando…

Safety and efficacy of tezepelumab vs. placebo in adult patients with severe uncontrolled asthma: a systematic review and meta-analysis

Patients with severe uncontrolled asthma still experience acute asthma symptoms and exacerbations, particularly those with non-eosinophilic inflammation who take the maximum amount of standard drug therapy. Tezepelumab, a human monoclonal antibody, can improve lung function and enhance control of as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shaban Abdelgalil, Mahmoud, Ahmed Elrashedy, Asmaa, Awad, Ahmed K., Reda Gad, Eman, Ali, Mahmoud M., Abdelmoez Farahat, Ramadan, Hassan Shawki, Bassant, Abd-ElGawad, Mohamed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719466/ https://www.ncbi.nlm.nih.gov/pubmed/36463281 http://dx.doi.org/10.1038/s41598-022-24763-9

Ejemplares similares

Does ozaki procedure have a future as a new surgical approach for aortic valve replacement? a systematic review and meta-analysis
por: K. Awad, Ahmed, et al.
Publicado: (2023)

Impact of Cotadutide drug on patients with type 2 diabetes mellitus: a systematic review and meta-analysis
por: Ali, Mahmoud M., et al.
Publicado: (2022)

Tezepelumab for Patients with Severe Uncontrolled Asthma: A Systematic Review and Meta-Analysis
por: Zoumot, Zaid, et al.
Publicado: (2022)

Sildenafil for congenital heart diseases induced pulmonary hypertension, a meta-analysis of randomized controlled trials
por: Awad, Ahmed K., et al.
Publicado: (2023)

Tezepelumab Efficacy in Patients with Severe, Uncontrolled Asthma with Comorbid Nasal Polyps in NAVIGATOR
por: Laidlaw, Tanya M, et al.
Publicado: (2023)

The Impact of Tezepelumab in Uncontrolled Severe Asthma: A Systematic Review of Randomized Controlled Trials
por: Roy, Pooja, et al.
Publicado: (2022)

Tezepelumab Efficacy in Patients with Severe, Uncontrolled Asthma with Comorbid Nasal Polyps in NAVIGATOR [Corrigendum]
Publicado: (2023)

Effect of Tezepelumab on Lung Function in Patients With Severe, Uncontrolled Asthma in the Phase 3 NAVIGATOR Study
por: Menzies-Gow, Andrew, et al.
Publicado: (2023)

The efficacy of oxytocin gel in postmenopausal women with vaginal atrophy: an updated systematic review and meta-analysis
por: Farahat, Ramadan Abdelmoez, et al.
Publicado: (2023)

Functionality and Performance of an Accessorized Pre-Filled Syringe and an Autoinjector for At-Home Administration of Tezepelumab in Patients with Severe, Uncontrolled Asthma
por: Alpizar, Sady, et al.
Publicado: (2021)

The efficacy and safety of tezepelumab in the treatment of uncontrolled asthma: A systematic review and meta-analysis of randomized controlled trials
por: Lin, Fei, et al.
Publicado: (2023)

CASCADE: a phase 2, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the effect of tezepelumab on airway inflammation in patients with uncontrolled asthma
por: Emson, Claire, et al.
Publicado: (2020)

NAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthma
por: Menzies-Gow, Andrew, et al.
Publicado: (2020)

Unmet need in severe, uncontrolled asthma: can anti-TSLP therapy with tezepelumab provide a valuable new treatment option?
por: Menzies-Gow, Andrew, et al.
Publicado: (2020)

Dupilumab and tezepelumab in severe refractory asthma: new opportunities
por: Ragnoli, Beatrice, et al.
Publicado: (2022)

Efficacy and Potential Positioning of Tezepelumab in the Treatment of Severe Asthma
por: Plaza, Vicente, et al.
Publicado: (2023)

DESTINATION: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the long-term safety and tolerability of tezepelumab in adults and adolescents with severe, uncontrolled asthma
por: Menzies-Gow, Andrew, et al.
Publicado: (2020)

Efficacy of Tezepelumab in Patients with Severe, Uncontrolled Asthma with and without Nasal Polyposis: A Post Hoc Analysis of the Phase 2b PATHWAY Study
por: Emson, Claire, et al.
Publicado: (2021)

Tezepelumab treatment for allergic bronchopulmonary aspergillosis
por: Ogata, Hiroaki, et al.
Publicado: (2023)

The Effect of Nitazoxanide on the Clinical Outcomes in Patients with COVID-19: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Abuelazm, Mohamed, et al.
Publicado: (2022)

Monkeypox and its research trends in Arab countries: A brief bibliometric analysis
por: Farahat, Ramadan Abdelmoez, et al.
Publicado: (2022)

Mapping Impossible Utilities: The ICER Report on Tezepelumab for Severe Asthma
por: Langley, Paul C
Publicado: (2022)

Tezepelumab Reduces Exacerbations Across All Seasons in Patients with Severe, Uncontrolled Asthma: A Post Hoc Analysis of the PATHWAY Phase 2b Study
por: Corren, Jonathan, et al.
Publicado: (2021)

Re-emergence of Marburg virus and monkeypox in the shadow of COVID-19 pandemic: Current situation and implications – Correspondence
por: Farahat, Ramadan Abdelmoez, et al.
Publicado: (2022)

The urgency of suicide prevention in Yemen: Challenges and recommendations – Correspondence
por: AL- Ahdal, Tarek, et al.
Publicado: (2022)

The resurfacing of hand, foot, and mouth disease: Are we on the verge of another epidemic?
por: Farahat, Ramadan Abdelmoez, et al.
Publicado: (2022)

Are congenital heart defects connected to more severe attention-deficit/hyperactivity disorder?: A systematic review and meta-analysis
por: Hasan, Mohammed Tarek, et al.
Publicado: (2023)

Molecular Targets for Biological Therapies of Severe Asthma: Focus on Benralizumab and Tezepelumab
por: Cheng, Shih-Lung
Publicado: (2021)

Tezepelumab as an Emerging Therapeutic Option for the Treatment of Severe Asthma: Evidence to Date
por: Dorey-Stein, Zachariah L, et al.
Publicado: (2021)

Tezepelumab: A Potential New Biological Therapy for Severe Refractory Asthma
por: Pelaia, Corrado, et al.
Publicado: (2021)

Baseline type 2 biomarker levels and response to tezepelumab in severe asthma
por: Corren, Jonathan, et al.
Publicado: (2022)

Developments in the Management of Severe Asthma in Children and Adolescents: Focus on Dupilumab and Tezepelumab
por: van Dijk, Yoni E., et al.
Publicado: (2023)

The potential promise and challenge for tezepelumab as a biologic therapy for severe asthma
por: Williams, Dennis M
Publicado: (2022)

Suicide in Egypt: Should it Be prevented or disregarded?
por: Farahat, Ramadan Abdelmoez, et al.
Publicado: (2022)

Current monkeypox outbreak: lessons from ancient history in Egyptian mummies?
por: Farahat, Ramadan Abdelmoez, et al.
Publicado: (2022)

Western Pacific countries preparedness for monkeypox emergence: A call for action – Correspondence
por: Farahat, Ramadan Abdelmoez, et al.
Publicado: (2022)

Disconnect for Tezepelumab on Exacerbations, Symptoms, and Quality of Life in Type 2 Low Asthma
por: Lipworth, Brian, et al.
Publicado: (2023)

Suicide prevention in Bangladesh: Hope and hype
por: Farahat, Ramadan Abdelmoez, et al.
Publicado: (2022)

Monkeys and Monkeypox: Are we on the brink of another stigma?
por: Farahat, Ramadan Abdelmoez, et al.
Publicado: (2022)

Omicron B.1.1.529 subvariant: Brief evidence and future prospects
por: Farahat, Ramadan Abdelmoez, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jki0ja6cpslh139j26csqak5dd